CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression-Reference-Cited by-同舟云学术

CBX3 accelerates the malignant progression of glioblastoma multiforme by stabilizing EGFR expression

Published:2022-04-22 Issue:22 Volume:41 Page:3051-3063
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Peng Wen,Shi Shuang,Zhong Jiacheng,Liang Hanghua,Hou Jianbin,Hu Xiaosong,Wang Feng,Zhang Jiayi,Geng Shengjun,Sun Xiaochuan,Zhong Dong^ORCID,Cui Hongjuan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-022-02296-9.pdf

Reference58 articles.

1. Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15:422–42.

2. Stathias V, Jermakowicz AM, Maloof ME, Forlin M, Walters W, Suter RK, et al. Drug and disease signature integration identifies synergistic combinations in glioblastoma. Nat Commun. 2018;9:5315.

3. Osuka S, Van Meir EG. Overcoming therapeutic resistance in glioblastoma: the way forward. J Clin Investig. 2017;127:415–26.

4. Zhao Y, He J, Li Y, Lv S, Cui H. NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR. Signal Transduct Target Ther. 2020;5:44.

5. Xuan F, Huang M, Liu W, Ding H, Yang L, Cui H. Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1. Neuro-Oncol. 2016;18:819–29.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cadherin-26 drives macrophage alternative activation via suppressing STUB1-mediated IL-4Rα ubiquitination in asthma;2024-08-02

2. Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy;Biomolecules;2024-04-15

3. ACAT1 promotes proliferation and metastasis of bladder cancer via AKT/GSK3β/c-Myc signaling pathway;Journal of Cancer;2024

4. Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer;Advanced Science;2023-11-10

5. Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11